Skip to main content

A Prospective Cohort Post Market Registry Evaluating Outcomes of Bridge-Enhanced ACL Restoration (BEAR®)

Active, not recruiting · NCT05398341

Conditions: Anterior Cruciate Ligament Injuries

At a glance

Research payments reported, 2025
$391,854
U.S. investigators named
7
Sites paid
7
Planned or actual enrollment
300

About the trial

Sponsor
Miach Orthopaedics
Tested
The BEAR® Implant (device)
Dates
Started 2023-02-28; completion 2027-01-30
Results posted
Not yet

The purpose of the Bridge Registry is to assess real-world performance of the FDA approved BEAR Implant.

From ClinicalTrials.gov, last updated 2026-06-09. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Miach Orthopaedics, Inc. reported $391,854 in research payments for this study in 2025 (7 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.